Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative ( UK ROC ): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative ( UK ROC ): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

Introduction: Clinical trials show improved progression‐free survival (PFS) and overall survival (OS) in first‐line metastatic renal cell carcinoma (mRCC) patients with immunotherapy containing systemic anti‐cancer therapies (SACT). However, in the favourable international metastatic renal cell canc...

Full description

Bibliographic Details
Main Authors: McGrane, J, Frazer, R, Challapalli, A, Ratnayake, G, Boh, Z, Clayton, A, Chau, C, Sharma, A, Elgendy, M, Charnley, N, Mohamed, W, Kingdon, S, Protheroe, A, Lydon, A, Halstead, A, Ford, V, Muazzam, I, Lee, D, Melendez‐Torres, GJ, Bahl, A
Format: Journal article
Language:English
Published: Wiley Open Access 2024

Similar Items